Emerging infectious diseases and AMR Flashcards

1
Q

Describe types of emerging infectious diseases

A

Caused by:

  • Previously undetected or unknown infectious agents eg COVID19
  • Known agents that have spread to new geographic locations or new populations e.g. Japanese encephalitis virus
  • Previously known agents whose role in specific diseases has previously gone unrecognized eg Zika
  • Re-emergence of agents whose incidence of disease had significantly declined in the past, but whose incidence of disease has reappeared (i.e., re-emerging infectious diseases) eg Syphilis in Au
  • Acquired resistance of pathogens to antimicrobials

Factors in (Re-)emergence of Infectious Diseases

  • Agent – evolution of pathogens over time, resistance, malnutrition/immunity
  • Host - immunosuppression; prolonged infection (cahance to adapt and resist)
  • Transmission – changing in living, behaviours, trade, travel, migration, interaction with animals
  • Environment – vectors and diseases spread to new areas as global warming accelerates

![[Pasted image 20240725194346.png]]
- in general, brings pathogen and people together
- ttemperature can also influnce replication and spread

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Describe the one health approach

A

Definition by the One Health High‐Level Expert Panel and adopted by the Quadripartite (FAO, WOAH, UNEP, WHO)

  • About 60% of global emerging infections are of zoonotic origin
  • Zoonoses are the source of new and re-emerging infectious diseases; some with pandemic potential
  • Control of zoonoses requires a One Health approach
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Discuss the recent avian flu outbreak

A

Highly pathogenic Avian Influenza A

  • A is divided into subtypes based on surface proteins haemagluttinin and neuraminidase
  • Human flu usu. H1/3
  • Avian flu usu. H5/7
  • ## transmits from wild aquatic birds to chickens or to cattle, which interact with the environment r host directly

Global and Local Situation

  • In 2020, a Clade (2.3.4.4b) of H5N1 emerged and has become widespread (back to wild birds), with Australia the only continent not yet affected
  • The virus has impacted dozens of mammals (unusual)
  • WHO current risk assessment to general public health: low
  • WHO current risk assessment to people with exposure: low-to-moderate
  • Australia has recently experienced outbreaks of other avian influenzas including H5N8 in poultry

Tracking Animal Spread
- Global AIV with Zoonotic Potential
- HPAI_incursion_risk_assessment_Australia.pdf and image Tom Benson

Predicting Future Spread – Including into Australia
- wild bird migartion patterns
- further influenced by weather patterns
Potential Impact on Animals and Ecosystems in Australia
- Could cause bird species extinctions and decrease in populations
- Could cause indirect ecological effects (increase in other species such as vectors, pest species)
- Mortality rates can be very high → large volume of dead birds → impacts on mental health and wellbeing (and physical health risks)
- Poultry → mass deaths or depopulation → financial impacts, food security, animal welfare implications

Human Cases of Avian Influenza

  • Relatively rare given how widespread the outbreak is
  • Approximately 30 cases, 15 severe/critical with 7 deaths
  • One severe case reported in a returned traveller in Australia
  • No confirmed human-to-human transmission
  • Human-to-human transmission unlikely unless reassortment occurs with human influenza virus during co-infection that will enable it to bind to specific receptors in human respiratory tract
  • Technical Report: Highly Pathogenic Avian Influenza A(H5N1) Viruses | Avian Influenza (Flu)

Bringing All the Sectors Together on Prevention and Control of Avian Influenza

Animal Health:
- Biosecurity at commercial poultry farms
- Surveillance of poultry and wild birds
- Vaccination
- Culling/decontamination at affected farms

Human Health:
- Food safety
- Hand hygiene and use of PPE
- Surveillance of people who have been exposed
- Vaccinations
- Antivirals
- Laboratory testing capability
- International collaboration via WHO on human cases and influenza surveillance

Ecosystem:
- Modelling of climatic conditions and species migration informs risk assessments

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Define AMR

A
  • Antimicrobial resistance (AMR) is the resistance of pathogenic organisms to anti-bacterial, anti-viral, anti-fungal, anti-parasitic, and other agents which were previously effective against them
  • “Superbugs” / multidrug-resistant bacteria are resistant to most classes of antibiotics (e.g., MRSA)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Discuss the health impacts of AMR

A

Infections Caused by Drug-Resistant Organisms:

  • Require prolonged and/or costlier treatments
  • Extend hospital stays (increased resourcing for staff, diagnostic testing, environmental cleaning, and personal protective equipment)
  • Necessitate additional doctor visits/healthcare use
  • Contact with animals with antibiotic-resistant infections can transfer resistant pathogens to humans and vice versa

Factors Contributing to Emergence of AMR
- mutations causing survival advantage enable cells to replicate and take over other populations
- contaminated crops or infected organisms are consumed by humans
- humans transmit in the community, or get antibiotics developing resistance, spread bacteria to patients and workers in health institutions –> community
Health Impacts of AMR

  • Deaths attributable to AMR every year compared to other major causes of death: 10 mil in 2050
    • Antimicrobial Resistance: Tackling a crisis for the health and wealth of nations, 2014.
  • Deaths attributable to AMR every year by 2050- high in Africa and Asia, increasing in all continents
    • Antimicrobial Resistance: Tackling a crisis for the health and wealth of nations, 2014.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Discuss N.gonorrhoeae as an example of AMR

A
  • Predominantly sexually transmitted
  • Common – increasing in the ACT particularly in young women
  • Urethritis and cervicitis, blood stream infection, joint infections
  • Often asymptomatic in women but can cause infertility even if asymptomatic
  • Infection in late pregnancy vertical transmission neonatal eye disease
  • Resistance to many antibiotics has emerged (penicillins, tetracyclines, fluoroquinolones, macrolides, oral cephalosporins)
  • Ceftriaxone (IM) is first-line therapy
  • Resistance to ceftriaxone is a major concern → SUPER GONORRHOEA

Highlights from AURA 2023

  • Antimicrobials continue to be prescribed in Australia at much higher rates than most European countries and Canada
  • High use of antimicrobials that are associated with AMR, particularly in private hospitals
  • Stagnated AMR improvements in hospital system but improvements in primary care
  • High rates of inappropriate prescribing for COPD
  • High rates of inappropriate use of antimicrobials for surgical prophylaxis
  • Increasing rates of critical AMR – particularly carbapenemase-producing Enterobacterales
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

What are some emerging AMR threats facing Aus?

A
  • different in healthcare settings vs the community
  • in healthcare: carbapenem resistant P. aeruginosa, VRSA
  • in community: cephalosporin-resistant non-typhoidal Salmonella enterica, multi-drug resistant Shigella species
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Discuss how AMR impact might be reduced

A

Reducing AMR impact
- preventing infections and spread of resistance
- tracking infections
- improving antibiotic stewardship
- developing new drugs and diagnostic tests to identify resistant organisms

-
### AMR Requires a Global Response

  • WHO’s Global Action Plan endorsed at WHA in May 2015
  • UN General Assembly held a high-level meeting on AMR in September 2016
  • Agreed to M&E in Global action plan (GAP)

Australia’s Response to Antimicrobial Resistance

The 2020 Strategy Focuses on 7 Objectives:

  1. Clear governance for antimicrobial resistance initiatives
  2. Prevention and control of infections and the spread of resistance
  3. Greater engagement in the combat against resistance
  4. Appropriate usage and stewardship practices
  5. Integrated surveillance and response to resistance and usage
  6. A strong collaborative research

agenda across all sectors
7. Strengthen global collaboration and partnerships

How well did you know this?
1
Not at all
2
3
4
5
Perfectly